MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 21.03.2026
Theratechnologies DSO 2011-2026 | THTX
DSO Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 82.9 | 66.1 | 55.9 | 128 | 24.7 | 43.1 | 50.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 128 | 24.7 | 64.5 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M |  USA |
 |
Lipocine
LPCN
|
3.76 M | $ 7.4 | 1.23 % | $ 39 M | USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
132 | $ 217.23 | -0.38 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 19.47 | 1.25 % | $ 910 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
239 | $ 8.28 | -1.84 % | $ 110 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
21.5 | $ 1.68 | 2.13 % | $ 610 M | USA |
 |
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
9.68 | $ 0.74 | 21.89 % | $ 8.48 M |  Israel |
 |
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | USA |
 |
Exelixis
EXEL
|
43.4 | $ 41.51 | 0.23 % | $ 11.3 B | USA |
 |
MediWound Ltd.
MDWD
|
47.6 | $ 16.64 | -1.42 % | $ 453 M | Israel |
 |
Mesoblast Limited
MESO
|
0.00568 | $ 14.31 | 2.07 % | $ 9.29 B |  Australia |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | Israel |
 |
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | USA |
 |
Genmab A/S
GMAB
|
97.9 | $ 25.73 | 0.19 % | $ 16.5 B | Danmark |
 |
Aytu BioScience
AYTU
|
150 | $ 2.61 | -0.76 % | $ 16.4 M | USA |
 |
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M |  Germany |
 |
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.34 | -1.92 % | $ 832 M | Canada |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
20.5 | $ 69.55 | -1.75 % | $ 11.1 B | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
Longeveron
LGVN
|
28.6 | $ 0.87 | -8.8 % | $ 15.3 B | USA |